14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
14位分析师评估福泰制药：你需要知道的
Vertex Pharmaceuticals (NASDAQ:VRTX) has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去三个月中，有14位分析师对Vertex Pharmicals（纳斯达克股票代码：VRTX）进行了分析，揭示了从看涨到看跌的不同观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $474.86, a high estimate of $555.00, and a low estimate of $376.00. This current average has increased by 6.67% from the previous average price target of $445.15.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标股价为474.86美元，最高估计为555.00美元，低估值为376.00美元。目前的平均价格较之前的平均目标价445.15美元上涨了6.67％。
Investigating Analyst Ratings: An Elaborate Study...
调查分析师评...
登录免费看全文
登录/注册